4.3687
Finanzdaten der Hcw Biologics Inc-Aktie (HCWB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
98.72%
0.00507
|
0.3948 | 0.4264 | 0.6189 | 1.1267 |
Cost Of Revenue |
98.72%
0.00405
|
0.3158 | 0.3411 | 0.4384 | 0.512 |
Gross Profit |
98.72%
0.00101
|
0.079 | 0.0853 | 0.1804 | 0.6147 |
|
39.27%
1.9668
|
3.2387 | 3.7755 | 15.32 | 8.1084 |
Interest Income/Expense |
3.11%
0.2558
|
0.2481 | 0.2234 | 0.1597 | - |
Benefits Costs and Expenses |
100.00%
-
|
32.59 | - | - | - |
Costs And Expenses |
51.91%
1.9709
|
4.0987 | 4.1167 | 15.75 | 8.6204 |
Operating Income/Loss |
37.79%
-1.9658
|
-3.1598 | -3.6902 | -15.14 | -7.4937 |
Income/Loss From Continuing Operations Before Tax |
100.02%
0.00507
|
-32.20 | 0.4264 | -15.28 | -7.4681 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
34.87%
-2.1969
|
-3.3733 | -3.9023 | -15.28 | -7.4681 |
|
34.87%
-2.1969
|
-3.3733 | -3.9023 | -15.28 | -7.4681 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3,720%
44.68
|
1.1696 | 37.82 | 37.82 | 37.22 |
Diluted Average Shares |
3,720%
44.68
|
1.1696 | 37.82 | 37.82 | 37.22 |
Basic Earnings Per Share |
16.67%
-0.05
|
-0.06 | -0.10 | -0.40 | -0.20 |
Diluted Earnings Per Share |
16.67%
-0.05
|
-0.06 | -0.10 | -0.40 | -0.20 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):